Genetic screening for cancer risks in newborns is being explored as a potential method to improve treatment outcomes, though it presents certain challenges.
The concept involves identifying mutations linked to cancer in infants shortly after birth. This proactive approach could provide doctors with an early start on treatment, potentially improving survival rates and quality of life for affected children.
However, the practice isn’t without risks. The source does not detail specific risks but notes that such screening “comes with risks.
The idea is gaining attention as a way to address childhood cancers more effectively. While currently not standard practice, the possibility of implementing widespread newborn cancer risk assessment is under consideration by medical professionals and researchers.
We don't rate truth. We strip the spin and show you which perspectives covered the story. You decide.
Read the original coverage
💬 Comments
📜 Comment Policy